PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Steve Yoder on Q4 2020 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc (PIRS) Q4 2020 Earnings Conference Call March 30, 2021, 08:00 AM ET Company Participants Tom Bures - VP, Finance Steve Yoder - President and CEO Hitto Kaufmann - Chief Scientific Officer Shane Olwill - SVP and Head, Translational Science Conference Call Participants Matt Phipps - William Blair Presentation Operator Greetings, and welcome to Pieris Pharmaceuticals Inc. Year-End Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I would now turn the conference over to your host, Tom Bures. You may begin. Tom Bures Thank you. Good morning, everyone, and thank you for joining us for our year-end 2020 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline;
For further details see:
Pieris Pharmaceuticals, Inc. (PIRS) CEO Steve Yoder on Q4 2020 Results - Earnings Call Transcript